MCT1 in invasive ductal carcinoma: Monocarboxylate metabolism and aggressive breast cancer Journal Article


Authors: Johnson, J. M.; Cotzia, P.; Fratamico, R.; Mikkilineni, L.; Chen, J.; Colombo, D.; Mollaee, M.; Whitaker-Menezes, D.; Domingo-Vidal, M.; Lin, Z.; Zhan, T.; Tuluc, M.; Palazzo, J.; Birbe, R. C.; Martinez-Outschoorn, U. E.
Article Title: MCT1 in invasive ductal carcinoma: Monocarboxylate metabolism and aggressive breast cancer
Abstract: Introduction: Monocarboxylate transporter 1 (MCT1) is an importer of monocarboxylates such as lactate and pyruvate and a marker of mitochondrial metabolism. MCT1 is highly expressed in a subgroup of cancer cells to allow for catabolite uptake from the tumor microenvironment to support mitochondrial metabolism. We studied the protein expression of MCT1 in a broad group of breast invasive ductal carcinoma specimens to determine its association with breast cancer subtypes and outcomes. Methods: MCT1 expression was evaluated by immunohistochemistry on tissue micro-arrays (TMA) obtained through our tumor bank. Two hundred and fifty-seven cases were analyzed: 180 cases were estrogen receptor and/or progesterone receptor positive (ER+ and/or PR+), 62 cases were human epidermal growth factor receptor 2 positive (HER2+), and 56 cases were triple negative breast cancers (TNBC). MCT1 expression was quantified by digital pathology with Aperio software. The intensity of the staining was measured on a continuous scale (0-black to 255-bright white) using a co-localization algorithm. Statistical analysis was performed using a linear mixed model. Results: High MCT1 expression was more commonly found in TNBC compared to ER+ and/or PR+ and compared to HER-2+ (p < 0.001). Tumors with an in-situ component were less likely to stain strongly for MCT1 (p < 0.05). High nuclear grade was associated with higher MCT1 staining (p < 0.01). Higher T stage tumors were noted to have a higher expression of MCT1 (p < 0.05). High MCT1 staining in cancer cells was associated with shorter progression free survival, increased risk of recurrence, and larger size independent of TNBC status (p < 0.05). Conclusion: MCT1 expression, which is a marker of high catabolite uptake and mitochondrial metabolism, is associated with recurrence in breast invasive ductal carcinoma. MCT1 expression as quantified with digital image analysis may be useful as a prognostic biomarker and to design clinical trials using MCT1 inhibitors. © 2017 Johnson, Cotzia, Fratamico, Mikkilineni, Chen, Colombo, Mollaee, Whitaker-Menezes, Domingo-Vidal, Lin, Zhan, Tuluc, Palazzo, Birbe and Martinez-Outschoorn.
Keywords: glycolysis; oxidative phosphorylation; lactic acid; tumor microenvironment; triple negative breast cancer
Journal Title: Frontiers in Cell and Developmental Biology
Volume: 5
Issue: APR
ISSN: 2296-634X
Publisher: Frontiers Media S.A.  
Date Published: 2017-04-03
Start Page: 43
Language: English
DOI: 10.3389/fcell.2017.00027
PROVIDER: scopus
PMCID: PMC5376582
PUBMED: 28421181
DOI/URL:
Notes: Article -- Export Date: 5 September 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paolo Cotzia
    16 Cotzia